This event will cover: new paradigms for targeted therapies, new anti-cancer agents ~ industry viewpoint, novel approaches to the treatment of breast cancer, melanoma and pancreatic cancer, drug development and precision radiotherapy, European drug development initiatives, market access to novel cancer drugs, regulatory issues in marketing authorisation of anti-cancer products, gene and cell therapies and trial endpoints and developing cancer vaccines.
Price: GBP 1275
Time: 9:00 am to 5:00 pm
Price: GBP 1275
Time: 9:00 am to 5:00 pm
